143 related articles for article (PubMed ID: 18496607)
1. The Interaction of Hydroxymandelate Synthase with the 4-Hydroxyphenylpyruvate Dioxygenase Inhibitor: NTBC.
Conrad JA; Moran GR
Inorganica Chim Acta; 2008 Mar; 361(4):1197-1201. PubMed ID: 18496607
[TBL] [Abstract][Full Text] [Related]
2. The rate-limiting catalytic steps of hydroxymandelate synthase from Amycolatopsis orientalis.
He P; Conrad JA; Moran GR
Biochemistry; 2010 Mar; 49(9):1998-2007. PubMed ID: 20112984
[TBL] [Abstract][Full Text] [Related]
3. Intermediate partitioning kinetic isotope effects for the NIH shift of 4-hydroxyphenylpyruvate dioxygenase and the hydroxylation reaction of hydroxymandelate synthase reveal mechanistic complexity.
Shah DD; Conrad JA; Moran GR
Biochemistry; 2013 Sep; 52(35):6097-107. PubMed ID: 23941465
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the mechanism of hydroxylation by 4-hydroxyphenylpyruvate dioxygenase and hydroxymandelate synthase from intermediate partitioning in active site variants.
Shah DD; Conrad JA; Heinz B; Brownlee JM; Moran GR
Biochemistry; 2011 Sep; 50(35):7694-704. PubMed ID: 21815644
[TBL] [Abstract][Full Text] [Related]
5. Two roads diverged: the structure of hydroxymandelate synthase from Amycolatopsis orientalis in complex with 4-hydroxymandelate.
Brownlee J; He P; Moran GR; Harrison DH
Biochemistry; 2008 Feb; 47(7):2002-13. PubMed ID: 18215022
[TBL] [Abstract][Full Text] [Related]
6. Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione.
Kavana M; Moran GR
Biochemistry; 2003 Sep; 42(34):10238-45. PubMed ID: 12939152
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of benzylic hydroxylation by 4-hydroxymandelate synthase. A computational study.
Wójcik A; Broclawik E; Siegbahn PE; Borowski T
Biochemistry; 2012 Nov; 51(47):9570-80. PubMed ID: 23126679
[TBL] [Abstract][Full Text] [Related]
8. 4-Hydroxyphenylpyruvate dioxygenase and hydroxymandelate synthase: exemplars of the α-keto acid dependent oxygenases.
Moran GR
Arch Biochem Biophys; 2014 Feb; 544():58-68. PubMed ID: 24211436
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
Ellis MK; Whitfield AC; Gowans LA; Auton TR; Provan WM; Lock EA; Smith LL
Toxicol Appl Pharmacol; 1995 Jul; 133(1):12-9. PubMed ID: 7597701
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic and computational studies of NTBC bound to the non-heme iron enzyme (4-hydroxyphenyl)pyruvate dioxygenase: active site contributions to drug inhibition.
Neidig ML; Decker A; Kavana M; Moran GR; Solomon EI
Biochem Biophys Res Commun; 2005 Dec; 338(1):206-14. PubMed ID: 16197918
[TBL] [Abstract][Full Text] [Related]
11. (4-Hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis: the basis for ordered substrate addition.
Johnson-Winters K; Purpero VM; Kavana M; Nelson T; Moran GR
Biochemistry; 2003 Feb; 42(7):2072-80. PubMed ID: 12590595
[TBL] [Abstract][Full Text] [Related]
12. Engineering p-hydroxyphenylpyruvate dioxygenase to a p-hydroxymandelate synthase and evidence for the proposed benzene oxide intermediate in homogentisate formation.
Gunsior M; Ravel J; Challis GL; Townsend CA
Biochemistry; 2004 Jan; 43(3):663-74. PubMed ID: 14730970
[TBL] [Abstract][Full Text] [Related]
13. Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.
Brownlee JM; Johnson-Winters K; Harrison DH; Moran GR
Biochemistry; 2004 Jun; 43(21):6370-7. PubMed ID: 15157070
[TBL] [Abstract][Full Text] [Related]
14. We two alone will sing: the two-substrate alpha-keto acid-dependent oxygenases.
He P; Moran GR
Curr Opin Chem Biol; 2009 Oct; 13(4):443-50. PubMed ID: 19625206
[TBL] [Abstract][Full Text] [Related]
15. 4-Hydroxyphenylpyruvate dioxygenase.
Moran GR
Arch Biochem Biophys; 2005 Jan; 433(1):117-28. PubMed ID: 15581571
[TBL] [Abstract][Full Text] [Related]
16. Tyrosinemia I, a model for human diseases mediated by 2-oxoacid-utilizing dioxygenases: hepatotoxin suppression by NTBC does not normalize hepatic collagen metabolism.
Hanauske-Abel HM; Popowicz A; Remotti H; Newfield RS; Levy J
J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):73-8. PubMed ID: 12142814
[TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxyphenylpyruvate dioxygenase: a hybrid density functional study of the catalytic reaction mechanism.
Borowski T; Bassan A; Siegbahn PE
Biochemistry; 2004 Sep; 43(38):12331-42. PubMed ID: 15379572
[TBL] [Abstract][Full Text] [Related]
18. Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.
Brownlee JM; Heinz B; Bates J; Moran GR
Biochemistry; 2010 Aug; 49(33):7218-26. PubMed ID: 20677779
[TBL] [Abstract][Full Text] [Related]
19. Crystal Structure of 4-Hydroxyphenylpyruvate Dioxygenase in Complex with Substrate Reveals a New Starting Point for Herbicide Discovery.
Lin HY; Chen X; Chen JN; Wang DW; Wu FX; Lin SY; Zhan CG; Wu JW; Yang WC; Yang GF
Research (Wash D C); 2019; 2019():2602414. PubMed ID: 31549053
[TBL] [Abstract][Full Text] [Related]
20. Catalytic, noncatalytic, and inhibitory phenomena: kinetic analysis of (4-hydroxyphenyl)pyruvate dioxygenase from Arabidopsis thaliana.
Purpero VM; Moran GR
Biochemistry; 2006 May; 45(19):6044-55. PubMed ID: 16681377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
